p63 inhibits CD44+/CD24- cell proliferation and chemoresistance in papillary thyroid carcinoma cells

p63抑制乳头状甲状腺癌细胞中CD44+/CD24-细胞的增殖和化疗耐药性

阅读:8
作者:Jing-Jing Guo ,Hong-Shun Xu ,Gang Wu ,Zhen-Yu Ma

Abstract

Thyroid cancer typically has a good prognosis; however, the risks of recurrence and chemoresistance associated with thyroid cancer remain a cause for concern. Papillary thyroid carcinoma (PTC) comprises 80% of all cases of thyroid carcinoma. A previous study reported that cluster of differentiation (CD) 44+/CD24- PTC cells may contribute to PTC recurrence and chemoresistance; however, the underlying molecular mechanisms remain elusive. In the present study, CD44+/CD24- cells were isolated from the TPC-1 PTC cell line and biological function assays revealed that CD44+/CD24- cells were significantly more proliferative and chemoresistant compared with CD44-/CD24- cells. Furthermore, the expression level of p63 was demonstrated to be negatively correlated with the expression of CD44 in PTC cells. The role of p63 in CD44+/CD24- cell proliferation and chemoresistance was investigated and, the ectopic expression of p63 was observed to significantly inhibit CD44+/CD24- cell proliferation and chemoresistance in vitro and in vivo. In conclusion, the present study indicated that CD44+/CD24- cells contribute to PTC proliferation and chemoresistance and that the suppression of p63 in CD44+/CD24- cells contributes to these effects.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。